General Announcement::ASX:NASDAQ:TLX: Q1 2026 Strong Revenue Growth and Tx Pipeline Advancement

Issuer & Securities

Issuer/ Manager
TELIX PHARMACEUTICALS LIMITED
Securities
TELIXPHAR A$650M2.375%N290730 - XS2862961492 - JWQB
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
07-Apr-2026 06:38:33
Status
New
Announcement Sub Title
ASX:NASDAQ:TLX: Q1 2026 Strong Revenue Growth and Tx Pipeline Advancement
Announcement Reference
SG260407OTHRPDAG
Submitted By (Co./ Ind. Name)
Nick Golding
Designation
Assistant Company Secretary
Effective Date and Time of the event
07/04/2026 06:40:00
Description (Please provide a detailed description of the event in the box below)
ASX:NASDAQ:TLX: Q1 2026 Strong Revenue Growth and Tx Pipeline Advancement

Attachments

20260407 Q1 2026 Business Update vFINAL.pdf
Total size =138K